Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins

Archives of Surgery

Volumn 134, Issue 1, 1999, Pages 43-49

  Bostick, Peter ^a   Essner, Richard ^a   Glass, Edwin ^a,b   Kelley, Mark ^a   Sarantou, Terry ^a   Foshag, Leland J ^a   Qi, Karen ^a   Morton, Donald ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b SAINT JOHN'S HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN TC 99M; DISULFINE BLUE; DYE; HUMAN SERUM ALBUMIN TC 99M; ISOSULFAN BLUE DYE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM ALBUMIN COLLOID TC 99M; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CLINICAL TRIAL; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SENTINEL NODE;

FEMALE; HUMANS; INTRAOPERATIVE CARE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; ROSANILINE DYES; SKIN NEOPLASMS;

EID: 0032960632     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.1.43     Document Type: Article

References (40)

1. Snow H. Melanotic cancerous disease. Cancer. 1892;2:872-875.
2. Milton GW, Shaw HH, McCarthy WJ, et al. Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1,319 patients. Br J Surg. 1982;69:108-111.
3. Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes: analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg. 1991;214:491-499.
4. Das Gupta TK. Results of treatment of 265 patients with primary cutaneous melanoma: a five-year prospective study. Ann Surg. 1977;186:201-209.
5. Day CL Jr, Mihm MC Jr, Lew RA, et al. Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51-3.99mm): a conceptual model for tumor growth and metastasis. Ann Surg. 1982;195:35-43.
6. Sim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Cancer. 1978;41:948-956.
7. Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med. 1977;297:627-630.
8. Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996;224:255-266.
9. Balch CM, Murad TM, Soong SJ, et al. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer. 1979;43:883-888.
10. Balch CM, Milton GW, Cascinelli N, Sims FH. Elective lymph node dissections: pros and cons. In: Balch CM, Houghton A, Milton GW, Sober AJ, Soongs SJ, eds. Cutaneous Melanoma. 2nd ed. Philadelphia, Pa: JB Lippincott; 1992;345-366.
11. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
12. Wong JH, Cagle LA, Morton DL. Lymphatic drainage of skin to a sentinel node in a feline model. Ann Surg. 1991;214:637-641.
13. Morton DL, Wen DR, Cochran AJ. Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy: an alternative to routine elective lymphadenectomy or "watch and wait." Surg Oncol Clin North Am. 1992;1:247-259.
14. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;220:759-767.
15. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995;5:255-260.
16. Karkakousis CP, Velez AF, Spellman JE, et al. The technique of sentinel node biopsy. Eur J Surg Oncol. 1996;22:271-275.
17. Essner R, Foshag L, Morton DL. Intraoperative radiolymphoscintigraphy: a useful adjuvant to intraoperative lymphatic mapping and selective lymphadenectomy in patients with clinical stage I melanoma. Paper presented at: Annual Meeting of the Society of Surgical Oncology: March 19, 1994: Houston, Tex.
18. Essner R. The role of lymphoscintigraphy and sentinel node mapping in assessing patient risk in melanoma. Semin Oncol. 1997;24:54-60.
19. Krag DN, Meijer SJ, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg. 1995;130:654-660.
20. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg. 1996;223:217-224.
21. Leong SPL, Steinmetz I, Habib FA, et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg. 1997;132:666-673.
22. Ronan SG, Eng AM, Briele HA, et al. Thin malignant melanomas with regression and metastasis. Arch Dermatol. 1987;123:1326-1330.
23. Soong SJ, Harrison RA, McCarthy WH, et al. Factors affecting survival following local, regional or distant recurrence from localized melanoma. J Surg Oncol 1998; 67:228-233.
24. Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med. 1998;39:1185-1190.
25. Hung JC, Wiseman GA, Wahner HW, et al. Filtered technetium-99m-sulfur colloid evaluated for lymphoscintigraphy. J Nucl Med. 1995;36:1895-1901.
26. Cochran AJ, Wen DR, Herschman HR. Occult melanoma in lymph nodes detected by antiserum to S-100 protein. Int J Cancer. 1984;34:159-163.
27. Campbell MJ, Machin D. Medical Statistics: A Commonsense Approach. 2nd ed. New York, NY: John Wiley & Sons Inc: 1995.
28. Fee HJ, Robinson DS, Sample WF, et al. The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study. Surgery. 1978;84:626-632.
29. Morton DL, Wen DR, Foshag LJ, Essner R, Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol. 1993;11:1751-1756.
30. Lamki LM, Logic JR. Defining lymphatic drainage patterns with cutaneous lymphoscintigraphy. In: Balch C, Houghton A, Milton GW, Sober AJ, Soong SJ, eds. Cutaneous Melanoma. 2nd ed. Philadelphia, Pa: JB Lippincott: 1992;367-375.
31. Norman J, Cruse CW, Espinosa C, et al. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg. 1991;162:432-437.
32. Pijpers R, Collet GJ, Meijer S, Hoekstra OS. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med. 1995;22:1238-1241.
33. Taylor A Jr, Murray D, Herda S, Vansant J, Alazraki N. Dynamic lymphoscintigraphy to identify the sentinel and satellite nodes. Clin Nucl Med. 1996;21:755-758.
34. Wong JH, Truelove K, Ko P, Coel MN. Localization and resection of an intransit sentinel lymph node by use of lymphoscintigraphy, intraoperative lymphatic mapping, and a hand-held gamma probe. Surgery. 1996;120:114-116.
35. O'Brien CJ, Uren RF, Thompson RF, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg. 1995;170:461-466.
36. Mudun A, Murray DR, Herda SC, et al. Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe. Radiology. 1996;199:171-175.
37. Loggie BW, Hosseinian AA, Watson NE, et al. Prospective evaluation of selective lymph node biopsy for cutaneous malignant melanoma. Am Surg. 1997;63: 1051-1056.
38. Wong JH, Terada K, Ko P, et al. Lack of effect of particle size on the identification of the sentinel node in cutaneous malignancies. Ann Surg Oncol. 1998;5:77-80.
39. Glass LF, Messina JL, Cruse W, et al. The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermatol Surg. 1996;22:715-720.
40. Bostick P, Essner R, Sarantou T, et al. Intraoperative lymphatic mapping for early-stage melanoma of the head and neck. Am J Surg. 1997;174:536-539.